Showing results (101-110 of 150) with videos related to
Sort By:
Pageof 15
ACS Infectious Diseases|June 30, 2022
Optimization of Benzoxazinorifamycins to Improve Mycobacterium tuberculosis RNA Polymerase Inhibition and Treatment of TuberculosisWalajapet Rajeswaran, Shireen R Ashkar, Pil H Lee, et al.Gene|July 13, 2004
Conserved amino acid sequences confer nuclear localization upon the Prophet of Pit-1 pituitary transcription factor proteinJ Chico Guy, Chad S Hunter, Aaron D Showalter, et al.Journal of Medicinal Chemistry|January 5, 1996
Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptorA J Bridges, H Zhou, D R Cody, et al.Journal of Labelled Compounds & Radiopharmaceuticals|March 5, 2019
Synthesis of deuterium-labelled amlexanox and its metabolic stability against mouse, rat, and human microsomesXinmin Gan, Michael W Wilson, Tyler S Beyett, et al.Nature Communications|March 15, 2012
Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium releaseDongbiao Shen, Xiang Wang, Xinran Li, et al.ACS Infectious Diseases|June 30, 2022
Optimization of Benzoxazinorifamycins to Minimize hPXR Activation for the Treatment of Tuberculosis and HIV CoinfectionShireen R Ashkar, Walajapet Rajeswaran, Pil H Lee, et al.Bioorganic & Medicinal Chemistry Letters|December 8, 2009
Design, synthesis and prostate cancer cell-based studies of analogs of the Rho/MKL1 transcriptional pathway inhibitor, CCG-1423Chris R Evelyn, Jessica L Bell, Jenny G Ryu, et al.Molecular Pharmacology|May 12, 2012
Allosteric modulation of endogenous metabolites as an avenue for drug discoveryDenise Wootten, Emilia E Savage, Celine Valant, et al.Journal of Medicinal Chemistry|January 6, 1995
Tyrosine kinase inhibitors. 4. Structure-activity relationships among N- and 3-substituted 2,2'-dithiobis(1H-indoles) for in vitro inhibition of receptor and nonreceptor protein tyrosine kinasesB D Palmer, G W Rewcastle, A M Thompson, et al.Plos One|April 4, 2014
A novel humanized GLP-1 receptor model enables both affinity purification and Cre-LoxP deletion of the receptorLucy S Jun, Aaron D Showalter, Nosher Ali, et al.Pageof 15